Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C

Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C

Medicaid prior authorization (PA) policies for treatment of hepatitis C virus (HCV) with direct‐acting antiviral (DAA) therapy are changing. We aimed to evaluate effects of changes in PA requirements on treatment uptake and to determine the factors associated with DAA treatment among Florida Medicai...

Full description

Bibliographic Details
Main Authors: Haesuk Park, Hyun Jin Song, Xinyi Jiang, Linda Henry, Robert L. Cook, David R. Nelson
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2021-02-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1634

Internet

https://doi.org/10.1002/hep4.1634

Similar Items